• Skip to main content

  • Home
  • News
    • New Funds
    • New Financings
    • People On the Move
    • Trends and Strategies
  • Transactions
    • New Platforms
    • New Add Ons
    • New Exits
  • Briefly
  • 2025 Salary Survey
  • Member Center
Please enter your username/email.
Please enter your password.
Login
Something went wrong. Please check your entries and try again.
PEP-logo-v9
Flag-small-6-28-24-120x73

May 21, 2026

Private equity's news leader since 2007

Chicago, Illinois

pep-superman-header-80x105-1

"There is a right and a wrong in the universe, and that distinction is not hard to make."

Superman

  • About Us
  • Membership
  • Webinars
  • Store
  • FAQs
  • Advertise With Us
  • Contact Us
Search

Archives for January 18, 2024

H.I.G. Relishes Buy of Patriot Pickle

January 18, 2024 by John McNulty

H.I.G. Capital has acquired Patriot Pickle from Swander Pace Capital.

Patriot Pickle is a maker of pickles and other fermented products including sauerkraut, peppers, and pickled green tomatoes that are sold in a range of cuts, flavors, and packaging formats including foodservice pails, retail quarts, and single-serve pouches.

Source : Adobe Stock

The company’s private label and branded products – sold under the K&Z, Regal Crown Foods, Natural Harvest, PickleAde, Farm Ridge Foods, and First Place brands – are sold through the foodservice channel to distributors, restaurant chains, supermarkets, and delis. Wayne, New Jersey-headquartered Patriot Pickle was founded in 2004 and has more than 115,000 square feet of production facilities. The company is led by Bill McEntee, its founder and president, and Adam Ricci, the company’s chief operating officer.

Swander Pace first invested in Patriot Pickle in April 2021. “Managing the complexity and intensity of rapidly growing businesses is hard work but partnering with Swander Pace made this process easier, and we had fun along the way. SPC’s strategic perspective, network, and broader insights were key enablers of the team’s success,” said Mr. McEntee.

“Patriot Pickle’s impressive platform has grown significantly over the years by delivering on its commitment to the highest quality pickles and best-in-class service,” said Justin Reyna, a managing director at H.I.G. “We are pleased to partner with Bill, Adam, and the Patriot team and look forward to supporting the company in its organic and acquisition-driven growth initiatives.”

H.I.G. specializes in providing debt and equity capital to small and medium-sized companies and invests in management buyouts, recapitalizations, and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.

H.I.G. is an experienced investor in the food and beverage industry with prior investments that include Lipari Foods (sold in 2022 to Littlejohn), Albertville Quality Foods (sold in 2017 to OK Foods), Tastes on the Fly (sold in 2023 to Paradies Lagardère), Ready Pac Foods (sold in 2017 to Bonduelle SA), Quick Restaurants (acquired in 2021), and Puerto de Indias (acquired in 2018).

MidCap Financial was the joint bookrunner and joint lead arranger on a senior secured credit facility to back the buy of Patriot Pickle. Managing Director T.J. Ceravolo led the MidCap transaction team. MidCap, in alliance with its investment manager Apollo Capital Management, is a middle-market-focused, specialty finance firm that provides debt instruments of $10 million to $750 million to companies across all industries.

Swander Pace invests in middle-market consumer products companies that have revenues of up to $500 million. Sectors of interest include food and beverage, body and wellness, and home and family. Swander Pace is headquartered in San Francisco with additional offices near New York City in Bedminster, New Jersey, and near Toronto in Mississauga, Ontario.

“It was a pleasure to work with the Patriot Pickle team. The team’s hard work and dedication have enabled a fantastic result and are a great example of SPC’s ability to partner with a founder to help accelerate growth and value. Patriot Pickle is a leader in the pickled and fermented foods category and is well-positioned for the future. We wish the team all the success going forward, and we are confident that Patriot Pickle will continue to deliver for its customers in the many years to come,” said Corby Reese and Tyler Matlock, managing directors at Swander Pace in a released statement.

William Blair and BMO Capital Markets were the financial advisors to H.I.G. on the purchase of Patriot Pickle.

© 2024 Private Equity Professional | January 19, 2024

Filed Under: New Platform, Transactions

Aterian Grows and Diversifies Allentown Platform

January 18, 2024 by John McNulty

Allentown, a portfolio company of Aterian Investment Partners, has closed the add-on acquisition of ClorDiSys Solutions.

Allentown is a provider of lab equipment used in the life sciences sector. The company’s products include reusable and single-use housing equipment for rodents, primates, rabbits, guinea pigs and poultry; biological safety cabinets; cabinet washing and sterilization; and monitoring and animal census systems.

Source: Allentown

Allentown’s customers include academic research institutions, pharmaceutical and biotechnology companies, private laboratories, governmental research institutions, and contract research organizations. The company was founded in 1968 by the Coiro family and is headquartered in Allentown, New Jersey.

The buy of ClorDiSys is the second add-on acquisition made by Allentown under Aterian ownership and follows the May 2023 buy of BetterBuilt, a manufacturer and installer of vivarium washing systems. Allentown was acquired by Aterian in April 2022 from Heartwood Partners.

ClorDiSys is a provider of chlorine dioxide-based solutions and ultraviolet light systems used for sterilizing and decontaminating vivariums, laboratory equipment and medical devices. Chlorine dioxide gas is an EPA registered sterilant capable of eliminating all microbiological contaminants including bacteria, viruses, molds, and spores.

Unlike other sterilization processes, ClorDiSys’ proprietary method of chlorine dioxide gas generation produces a non-acidic gas that is gentle on materials and electronics, does not result in harmful residues, is non-carcinogenic, and non-explosive.

Source: ClorDiSys Solutions

In addition to its equipment, ClorDiSys also provides a range of decontamination services for laboratories, clean rooms, pharmaceutical manufacturing areas, food processing areas, vivarium research facilities, and processing equipment. ClorDiSys was founded in 2001 and is headquartered near Newark in Branchburg, New Jersey.

The buy of ClorDiSys bolsters Allentown’s presence in the sterilization and decontamination of vivarium research facilities and introduces Allentown to the adjacent and attractive medical device sterilization market.

“Being acquired by Allentown is exactly what we needed to broaden our reach and make our services available to many more research institutions and adjacent industries,” said Paul Lorcheim, a director and co-founder of ClorDiSys. “We want to lead the world and be the catalyst of driving a better and healthier process and shift away from ethylene oxide for medical device sterilization and into ClorDiSys’ chlorine dioxide gas sterilization technology. ClorDiSys is quickly expanding into the medical device sterilization market, tripling the number of locations utilizing our technology in the last year alone. Unlike ethylene oxide, our process is more efficient, non-carcinogenic, non-explosive and greatly reduces the impact on the environment.”

“The acquisition of ClorDiSys represents core strategic initiatives to Allentown of expanding its total addressable market and introducing Allentown to sanitation, disinfection, and decontamination services,” said Daniel Phan, a managing director at Aterian. “As a family-owned and operated company we were thoroughly impressed by ClorDiSys’ products, services and customer-centric solutions and couldn’t be more excited about the partnership together. Allentown continues to establish itself as the acquisition platform of choice as we continue to transform Allentown into a broader solutions provider in the life sciences market.”

“We are thrilled to partner with ClorDiSys and look forward to welcoming the team to the Allentown family” said Charles Simmons, the chief executive officer of Allentown. “In pursuing our strategy to provide a full spectrum of high-science equipment, consumables and services to our trusted biomedical research customers and broadening our offerings and scientific services into adjacent life science industries, we’re thrilled when we find a leading organization that can help us pursue our goals. ClorDiSys is that type of company, offering innovative and effective decontamination solutions with integrity and care, perfectly aligned with our cause to improve science and lifesaving research. We are strong believers in ClorDiSys’ proven solutions to better serve our overlapping and complementary customer bases by providing our customers with a one-stop solution to further address their vivarium needs.”

“ClorDiSys is a highly strategic fit within Allentown’s portfolio of products and services, and we look forward to leveraging Allentown’s broader infrastructure, personnel talent and customer relationships to drive accelerated results,” said Jorge Fabre, a principal at Aterian.

Aterian invests from $10 million to $100 million in middle market businesses with $50 million to $750 million in revenue and $10 million to $50 million in EBITDA. The firm’s latest fund, Aterian Investment Partners IV LP, closed in October 2021 with $830 million of committed capital. Aterian has offices in New York City and Coral Gables, Florida.

© 2024 Private Equity Professional | January 19, 2024

Filed Under: New Platform, Transactions

Clearlake Successfully Closes the Door on Janus Investment

January 18, 2024 by John McNulty

Clearlake Capital has sold all its remaining shares of Janus International Group (NYSE: JBI) and has now fully exited its investment in the company.

Clearlake acquired Janus from Saw Mill Capital in February 2018. In June 2021, Clearlake took Janus public through a merger with Juniper Industrial, a “blank check” company that traded on the NYSE under the ticker symbol JIH. Following the Janus-Juniper combination, the stock traded under the symbol JBI.

Janus is a manufacturer and supplier of roll up and swing doors, hallway systems used in industrial and commercial facilities; and re-locatable storage units used in the self-storage industry. The company also provides design, consulting and installation services in support of its products.

Source: Janus International

Janus, led by CEO Ramey Jackson, has seven operating facilities in the US, three locations in Europe, two in Australia, and a joint venture in Mexico. The company’s US headquarters is located 40 miles west of Atlanta in Temple, Georgia; and its European headquarters is located near London in Twickenham, UK.

During Clearlake’s ownership term, Janus developed several new access control technologies (now sold under the Nokē brand) and closed seven add-on acquisitions including Georgia-based Asta Door (September 2017), UK-based Active Supply and Design (January 2018), North Carolina-based BETCO (January 2019), Utah-based Nokē (January 2019), Australia-based Steel Storage (January 2020), North Carolina-based Access Control (October 2021), and Georgia-based DCBI (July 2021).

“We are proud of the partnership with Clearlake and the experience and resources they dedicated to our business over the years,” said Mr. Jackson. “It has been an absolute pleasure working alongside their team to build Janus into the industrial technology platform it is today.”

For the full year 2023, Janus is estimated to have revenue of $1.1 billion (up 6% from the prior year) and Adjusted EBITDA of $285 million (up 25% from the prior year).

“We believe the growth and strategic transformation executed at Janus in partnership with management is a compelling story,” said José E. Feliciano, a co-founder and managing partner, and Colin Leonard, a partner, at Clearlake. “Our thesis to partner with Janus was centered around the company’s market position, value proposition, margins, and free cash flow, as well as the potential we saw for both organic and inorganic growth. Together with management, we achieved over 140% EBITDA growth and made investments to transition the business to a public company. Clearlake is proud to have partnered with CEO Ramey Jackson and his management team and looks forward to following the company’s future successes.”

“Janus is an example of our O.P.S. (Operations, People, and Strategy) value creation framework in action,” added Nate Mejías, a principal at Clearlake. “In a few short years, Ramey and his team executed an effective buy-and-build playbook, bolstered the management team, diversified the business, grew internationally, and led the adoption of additional technologies within the category.”

Clearlake invests in industrials and energy, software and technology-enabled services, and consumer sectors. The firm was co-founded by José Feliciano and Behdad Eghbali in 2006 and is headquartered in Santa Monica, California. In May 2022, Clearlake held a hard cap and oversubscribed final close of its seventh private equity fund, Clearlake Capital Partners VII LP, with $14.1 billion in commitments.

© 2024 Private Equity Professional | January 19, 2024

Filed Under: Exit, Transactions

Windjammer’s Sixth Fund Closes at $1.3 Billion

January 18, 2024 by John McNulty

Windjammer Capital Investors has closed its sixth fund, Windjammer Capital Fund VI LP, at its hard cap with $1.3 billion in capital commitments, markedly higher than its $1 billion target and 48% higher than the firm’s $870 million fifth fund.

According to Windjammer, new and returning limited partners in Fund VI include private and public pensions, family offices, insurance companies and asset managers.

“The success of this fundraise was highlighted by the backing from both existing and new investors, who understand and value the model we’ve built which focuses on finding investments whose core investment attributes provide downside protection as well as significant upside,” said Gregory Bondick, a managing principal of Windjammer. “We’re very appreciative of our investors’ support, particularly given the challenging environment, and look forward to working hard to reward their faith in Windjammer.”

“Investment in our operational resources has been critical to our partnerships with founders, entrepreneurs, and senior leadership teams at our portfolio companies,” said Jeffrey Miehe, a managing principal of Windjammer. “The capabilities our team brings for Fund VI, as with previous funds, are directed at helping our companies focus on growth and development and implementation of key operational initiatives that drive expansion of revenue and profits.”

Windjammer invests equity and subordinated debt as a control investor in middle-market businesses located in the US or Canada that have EBITDA from $8 million to $50 million. Sectors of interest include niche manufacturing, business services and value-added distribution. The firm’s investment size ranges from $50 million to $200 million per transaction.

In November 2023, Windjammer acquired its first Fund VI portfolio company with the buy of Bio X Cell, a New Hampshire-based producer of monoclonal antibodies used in both in vivo and in vitro pre-clinical research applications. The company’s portfolio of more than 400 functional grade antibodies are used by more than 1,500 academic, government and commercial customers for research into cancer, immunology and neuroscience.

“Bio X Cell’s niche market leadership and mission critical, low cost-to-value product offering reflect the business model characteristics that have always been core to our investment strategy,” said Mr. Bondick.

UBS Securities and Credit Suisse Securities were the placement agents for Fund VI and Kirkland & Ellis provided legal services.

With the close of Fund VI, Windjammer has now raised and managed more than $3 billion of capital and completed more than 60 platform investments and 160 strategic add-ons throughout its history. Windjammer was founded in 1990 and is based in Waltham, Massachusetts, and Newport Beach, California.

© 2024 Private Equity Professional | January 18, 2024

Filed Under: New Funds, News

PEP_mainlogo_White

Private Equity Professional
c/o Sun Business Media
PO Box 6610
Evanston, Illinois 60204
Office Direct (847) 920-8010

[email protected]

News

  • Platforms
  • Add Ons
  • Exits
  • Funds
  • Financings
  • People
  • Strategies

Customer Help

  • Why Advertise?
  • PEP Media Kit

Memberships

  • Individual

Advertising

  • Why Advertise?
  • PEP Media Kit

© 2026 Private Equity Professional. All Rights Reserved.